150 related articles for article (PubMed ID: 35778940)
1. Topical chlormethine gel in the treatment of mycosis fungoides: A single-center real-life experience and systematic review of the literature.
Laghi A; Franceschini C; Mandel VD; Teoli M; Musicco F; Sansone M; La Malfa AM; Ardigò M
Dermatol Ther; 2022 Sep; 35(9):e15683. PubMed ID: 35778940
[TBL] [Abstract][Full Text] [Related]
2. Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience.
Garcia-Saleem TJ; Stonesifer CJ; Khaleel AE; Geskin LJ
Acta Derm Venereol; 2021 Sep; 101(9):adv00544. PubMed ID: 34436621
[TBL] [Abstract][Full Text] [Related]
3. The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
Kim EJ; Guitart J; Querfeld C; Girardi M; Musiek A; Akilov OE; Angello JT; Bailey WL; Geskin LJ
Am J Clin Dermatol; 2021 May; 22(3):407-414. PubMed ID: 33656660
[TBL] [Abstract][Full Text] [Related]
4. Chlormethine Gel for the Treatment of Mycosis Fungoides (Cutaneous T-cell Lymphoma) in Canada.
Gniadecki R; Paron E
Skin Therapy Lett; 2023 Mar; 28(2):1-5. PubMed ID: 37054720
[TBL] [Abstract][Full Text] [Related]
5. Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study.
Correia E; Krishnasamy S; Suriano JG; Shi W; Alpdogan SO; Sahu J; Porcu P; Nikbakht N
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):581-588. PubMed ID: 35393251
[TBL] [Abstract][Full Text] [Related]
6. Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects
Prag Naveh H; Amitay-Laish I; Zidan O; Leshem YA; Sherman S; Noyman Y; Taieb J; Didkovsky E; Hodak E
J Dermatolog Treat; 2022 Jun; 33(4):2364-2370. PubMed ID: 34427536
[TBL] [Abstract][Full Text] [Related]
7. Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports.
Lampadaki K; Koumourtzis M; Karagianni F; Marinos L; Papadavid E
Adv Ther; 2021 Jun; 38(6):3455-3464. PubMed ID: 33928511
[TBL] [Abstract][Full Text] [Related]
8. Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.
Querfeld C; Scarisbrick JJ; Assaf C; Guenova E; Bagot M; Ortiz-Romero PL; Quaglino P; Bonizzoni E; Hodak E
Dermatology; 2022; 238(2):347-357. PubMed ID: 34091453
[TBL] [Abstract][Full Text] [Related]
9. Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings.
Wehkamp U; Ardigò M; Papadavid E; Querfeld C; Nikbakht N
Adv Ther; 2022 Sep; 39(9):3979-4002. PubMed ID: 35852707
[TBL] [Abstract][Full Text] [Related]
10. Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.
Geskin LJ; Bagot M; Hodak E; Kim EJ
Dermatol Ther (Heidelb); 2021 Aug; 11(4):1085-1106. PubMed ID: 34021485
[TBL] [Abstract][Full Text] [Related]
11. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
[TBL] [Abstract][Full Text] [Related]
12. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
13. Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study.
Querfeld C; Nelson WW; Gor D; Pashos CL; Doan QV; Turini M; Angello JT; Geskin LJ
Dermatol Ther (Heidelb); 2022 Dec; 12(12):2781-2795. PubMed ID: 36284059
[TBL] [Abstract][Full Text] [Related]
14. Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel.
Denis D; Beneton N; Laribi K; Maillard H
Cancer Manag Res; 2019; 11():2241-2251. PubMed ID: 30962713
[TBL] [Abstract][Full Text] [Related]
15. Chlormethine Gel is Efficient and Safe in Mycosis Fungoides Skin Lesions.
Koumourtzis M; Lampadaki K; Dalamaga M; Papadavid E
Acta Derm Venereol; 2022 Jun; 102():adv00730. PubMed ID: 35199177
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
Benjamin Chase A; Markel K; Tawa MC
Clin J Oncol Nurs; 2015 Dec; 19(6):E131-9. PubMed ID: 26583648
[TBL] [Abstract][Full Text] [Related]
17. Use of chlormethine 0.04% gel for mycosis fungoides after treatment with topical chlormethine 0.02% gel: A phase 2 extension study.
Querfeld C; Kim YH; Guitart J; Scarisbrick J; Quaglino P
J Am Acad Dermatol; 2022 Jul; 87(1):209-211. PubMed ID: 34333079
[No Abstract] [Full Text] [Related]
18. Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides.
Alexander-Savino CV; Chung CG; Gilmore ES; Carroll SM; Poligone B
Dermatol Ther (Heidelb); 2022 Mar; 12(3):643-654. PubMed ID: 35122614
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of chlormethine gel in mycosis fungoides.
Guenova E; Ortiz-Romero PL; Poligone B; Querfeld C
J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1739-1748. PubMed ID: 37262305
[TBL] [Abstract][Full Text] [Related]
20. Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data.
Querfeld C; Scarisbrick JJ; Assaf C; Kim YH; Guitart J; Quaglino P; Hodak E
Am J Clin Dermatol; 2022 Jul; 23(4):561-570. PubMed ID: 35536441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
